lower risk – Page 15 – Communicable Diseases Research

Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study

Observational Study

Published on 2021-10-282022-10-04
Journal: PLoS ONE [Category] Coronavirus, MERS, SARS, 임상,

Induction of trained immunity by influenza vaccination – impact on COVID-19

인플루엔자 예방접종을 통한 훈련된 면역 유도 - 코로나19에 미치는 영향

Observational Study

Published on 2021-10-252022-09-10
Journal: PLoS Pathogens [Category] MERS, 유전자 메커니즘, 임상,

[키워드] affected anti-SARS-CoV-2 assays caused claimed COVID-19 COVID-19 incidence COVID-19 vaccine cross-protection decrease distribution Effects epidemiological Epidemiological study fine-tune flu healthcare worker help hospital identify Immune cell immune cells immune responses Immunity immunological inactivated induction Influenza influenza vaccination influenza vaccine innate immune response innate immune responses Innate immunity investigated less lower risk mechanism mind monocyte Monocytes observation pandemic potential benefit potential benefits protective effect proteomics randomized trial reduced Relative risk reported reveal risk reduction Safe SARS-CoV-2 SARS-COV-2 infection Seasonal influenza Single-cell RNA sequencing suggested systemic inflammation transcriptional vaccination vaccination against COVID-19 Vaccine variant Viral virus
[DOI] 10.1371/journal.ppat.1009928 PMC 바로가기 [Article Type] Observational Study

Differences in Perceived Risk of Contracting SARS-CoV-2 during and after the Lockdown in Sub-Saharan African Countries

Article

Published on 2021-10-212022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, SARS,

Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study

Research

Published on 2021-10-192022-10-29
Journal: Journal of Hematology & Oncology [Category] COVID-19, MERS, SARS,

Differences in Sources of Information, Risk Perception, and Cognitive Appraisals between People with Various Latent Classes of Motivation to Get Vaccinated against COVID-19 and Previous Seasonal Influenza Vaccination: Facebook Survey Study with Latent Profile Analysis in Taiwan

Article

Published on 2021-10-192022-10-28
Journal: Vaccines [Category] COVID-19,

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

면역매개염증질환 및 코로나19 환자에서 종양괴사인자억제제와 입원 또는 사망 위험 간의 연관성

Research

Published on 2021-10-182022-09-12
Journal: JAMA Network Open [Category] MERS, SARS, 진단,

[키워드] 6-mercaptopurine 95% CI accounted accounting Adult patients age Analysis Arthritis association azathioprine category Clinical characteristics cohort study Combination conducted correlations country COVID-19 COVID-19 diagnosis Crohn disease data entry death demographic and clinical characteristics diagnose Diagnosis died Europe excluded exposure Factor female finding higher odd higher odds Hospitalization Hospitalized immune pathway Immune-mediated inflammatory disease Immune-mediated inflammatory diseases immunomodulatory Importance individual Inflammatory arthritis Inflammatory bowel disease Inflammatory diseases inhibitor International Janus kinase Kinase inhibitor lower risk measure methotrexate monotherapy multivariable logistic regression Necrosis objective Odds ratio outcome pandemic participant Patient Point psoriasis receipt receiving reference treatment Relevance reported reporting bias Result Rheumatic diseases rheumatoid arthritis risk Sensitivity analyses sensitivity analysis setting significantly higher Support Symptom the mean therapy TNF treatment regimen Tumor tumor necrosis tumor necrosis factor
[DOI] 10.1001/jamanetworkopen.2021.29639 PMC 바로가기 [Article Type] Research

The association between early country‐level COVID‐19 testing capacity and later COVID‐19 mortality outcomes

Original Article

Published on 2021-10-142022-10-30
Journal: Influenza and Other Respiratory Viruses [Category] COVID-19, MERS, SARS,

Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19

SARS-COV-2 양성 환자에 대해 수행 된 초기 두 번째 PCR 검사 결과는 심각한 COVID-19에 대한 위험 평가를 지원할 수 있습니다.

Article

Published on 2021-10-142022-09-01
Journal: Scientific Reports [Category] MERS, SARS, 바이오마커, 진단, 치료기술, 치료법,

HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study

Observational Study

Published on 2021-10-142022-10-04
Journal: PLoS Medicine [Category] MERS, 임상,

[키워드] 95% CI adjusted age Analysis analyzed Anticoagulant association calculated cardiovascular disease cause Coagulation Cohort cohort study Comorbidity condition COVID-19 COVID-19 mortality COVID-19 pandemic defined determine diagnosed died drug drug regimens example Factors female Follow-up groups hazard hazard ratio Health health condition healthcare heterogeneity HMG-CoA reductase HRs hyperlipidemia immune immune system include individual inhibitor initiated ischemic heart disease less limitation lower risk male mechanisms Mortality multivariable multivariable Cox regression observational study Older performed pleiotropic effect population-based cohort prescription previous study randomized clinical trials randomized trial recommendation recommendations recorded registry researcher resulting risk sensitivity analysis statin Study design Support survival Swedish therapeutic effect Topic Treatment Trial while with COVID-19
[DOI] 10.1371/journal.pmed.1003820 PMC 바로가기 [Article Type] Observational Study

A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19

CTCF 결합을 방해하는 인터루킨-6의 저생산 일배체형은 심각한 COVID-19를 예방합니다

Research Article

Published on 2021-10-122022-09-10
Journal: mBio [Category] MERS, 변종,

[키워드] 95% confidence interval allele Analysis antisense Asia Asian bidirectional transcription carrier carriers Chinese conserved correlated COVID-19 COVID-19 patient COVID-19 severity CTCF defined Disease progression disturbance element Endemic enhancer expression functional genetic polymorphisms Genotype Haplotype Human humans hyperinflammation IL-6 IL-6 blockade IL-6 expression induce Inflammatory responses inflammatory stimuli interleukin-6 intronic SNP intronic SNPs loci locus long noncoding RNA lower risk Mild Neanderthal Odds ratio outcome patients polymorphism Polymorphisms promoter Protective Quantitative reduced severe symptom severe symptoms severity significantly single-nucleotide Single-nucleotide polymorphisms SNP SNPs T allele therapy transcribed Variability variant Viral viral infection with COVID-19
[DOI] 10.1128/mBio.01372-21 PMC 바로가기 [Article Type] Research Article